Increasing prevalence of high-grade dysplasia and adenocarcinoma on index endoscopy in Barrett’s esophagus

Post written by Madhav Desai, MD, MPH, from the Gastroenterology and Hepatology, University of Kansas Medical Center, Kansas City, Kansas, USA. Barrett’s esophagus (BE) is a known precursor lesion for esophageal adenocarcinoma (EAC), and we know that incidence of the latter is rising in last 30 years thereby necessitating early detection and management of this …

Continue reading Increasing prevalence of high-grade dysplasia and adenocarcinoma on index endoscopy in Barrett’s esophagus

A trial comparing a 25-gauge EUS-FNA device with a 20-gauge EUS-FNB device

Post written by Priscilla A. van Riet, MD, from the Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, the Netherlands. Our study focused on the optimization of EUS-guided tissue sampling. For this, we compared the diagnostic performance of a newly designed FNB needle, the 20G ProCore needle with a forward-facing bevel, to …

Continue reading A trial comparing a 25-gauge EUS-FNA device with a 20-gauge EUS-FNB device

Editor’s Choice: Role of interventional inflammatory bowel disease in the era of biologic therapy

GIE Senior Associate Editor, Dr. John R. Saltzman, MD, highlights this article from the February issue “Role of interventional inflammatory bowel disease in the era of biologic therapy: a position statement from the Global Interventional IBD Group” by Bo Shen, MD, et al.  There is an increasing recognition that Interventional (or therapeutic) inflammatory bowel disease …

Continue reading Editor’s Choice: Role of interventional inflammatory bowel disease in the era of biologic therapy

Role of interventional inflammatory bowel disease in the era of biologic therapy

Post written by Bo Shen, MD, from the Department of Gastroenterology and Hepatology, Cleveland Clinic, Cleveland, Ohio, USA. The team from the Global Interventional IBD (Gi-IBD) group and ASGE Special Interest Group in Interventional IBD put together a position statement on endoscopic management of structural and neoplastic complications of IBD. With better understanding of etiology, …

Continue reading Role of interventional inflammatory bowel disease in the era of biologic therapy

Annular pancreas: endoscopic and pancreatographic findings

Post written by Evan L. Fogel, MD, MSc, from the Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA. Annular pancreas is a rare congenital anomaly most often diagnosed in children, but it may be seen in adults as well. It is an entity in which pancreatic tissue …

Continue reading Annular pancreas: endoscopic and pancreatographic findings

Blue laser imaging-bright improves the real-time detection rate of early gastric cancer

Post written by Osamu Dohi, MD, PhD, from the Department of Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, and the Department of Gastroenterology and Hepatology, North Medical Center, Kyoto Prefectural University of Medicine, Kyoto, Japan. Blue laser imaging (BLI) is one of the image-enhanced endoscopic techniques with a combination of 2 narrow lasers. …

Continue reading Blue laser imaging-bright improves the real-time detection rate of early gastric cancer

Index colonoscopy-related risk factors for postcolonoscopy colorectal cancers

Post written by Theodore A. Tollivoro, MD, from the Division of Research, Kaiser Permanente Northern California, Oakland, California, USA. Over the last 20 years, we have realized the importance of quality metrics as they apply to colonoscopic exam. We track physician adenoma detection rates, cecal intubation rates, and ensure our patients undergo exams with optimal …

Continue reading Index colonoscopy-related risk factors for postcolonoscopy colorectal cancers